Boston Trust Walden Corp Sells 8,835 Shares of Plexus Corp. $PLXS

Boston Trust Walden Corp decreased its position in Plexus Corp. (NASDAQ:PLXS) by 2.3% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 369,413 shares of the technology company’s stock after selling 8,835 shares during the quarter. Boston Trust Walden Corp’s holdings in Plexus were worth $49,985,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. BNP PARIBAS ASSET MANAGEMENT Holding S.A. boosted its stake in Plexus by 0.6% in the 1st quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. now owns 975,612 shares of the technology company’s stock valued at $125,005,000 after purchasing an additional 6,257 shares during the period. American Century Companies Inc. increased its position in Plexus by 24.7% during the first quarter. American Century Companies Inc. now owns 678,222 shares of the technology company’s stock worth $86,901,000 after acquiring an additional 134,205 shares during the period. Fuller & Thaler Asset Management Inc. increased its position in Plexus by 120.4% during the first quarter. Fuller & Thaler Asset Management Inc. now owns 348,510 shares of the technology company’s stock worth $44,655,000 after acquiring an additional 190,360 shares during the period. Millennium Management LLC grew its position in shares of Plexus by 85.1% during the 1st quarter. Millennium Management LLC now owns 228,116 shares of the technology company’s stock worth $29,229,000 after purchasing an additional 104,904 shares in the last quarter. Finally, Invesco Ltd. grew its position in shares of Plexus by 66.1% during the 1st quarter. Invesco Ltd. now owns 211,741 shares of the technology company’s stock worth $27,130,000 after purchasing an additional 84,249 shares in the last quarter. Institutional investors and hedge funds own 94.45% of the company’s stock.

Insider Activity

In related news, CAO Angelo Michael Ninivaggi, Jr. sold 1,576 shares of the stock in a transaction on Monday, August 25th. The stock was sold at an average price of $137.78, for a total value of $217,141.28. Following the completion of the sale, the chief accounting officer directly owned 24,495 shares in the company, valued at $3,374,921.10. This represents a 6.05% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, COO Oliver K. Mihm sold 2,102 shares of the stock in a transaction on Friday, August 15th. The shares were sold at an average price of $130.43, for a total value of $274,163.86. Following the completion of the sale, the chief operating officer owned 21,155 shares of the company’s stock, valued at $2,759,246.65. The trade was a 9.04% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 15,856 shares of company stock valued at $2,142,440. 1.76% of the stock is currently owned by company insiders.

Analyst Ratings Changes

Several brokerages recently issued reports on PLXS. Benchmark boosted their price target on Plexus from $160.00 to $165.00 and gave the company a “buy” rating in a research note on Monday, September 22nd. Williams Trading set a $165.00 price target on Plexus in a research report on Monday, September 22nd. Sidoti upgraded shares of Plexus from a “neutral” rating to a “buy” rating and increased their price objective for the stock from $135.00 to $150.00 in a research note on Friday, July 25th. Weiss Ratings reiterated a “hold (c+)” rating on shares of Plexus in a research note on Wednesday, October 8th. Finally, Wall Street Zen raised shares of Plexus from a “buy” rating to a “strong-buy” rating in a report on Saturday. Three investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to MarketBeat, Plexus presently has an average rating of “Moderate Buy” and a consensus price target of $155.60.

Plexus Price Performance

Plexus stock opened at $138.06 on Tuesday. The company has a current ratio of 1.58, a quick ratio of 0.74 and a debt-to-equity ratio of 0.06. The company has a market capitalization of $3.73 billion, a PE ratio of 23.52 and a beta of 0.80. Plexus Corp. has a 12 month low of $103.43 and a 12 month high of $172.89. The stock has a 50-day moving average price of $137.98 and a two-hundred day moving average price of $132.27.

Plexus (NASDAQ:PLXS) last released its quarterly earnings data on Wednesday, July 23rd. The technology company reported $1.90 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.71 by $0.19. Plexus had a return on equity of 12.33% and a net margin of 4.04%.The company had revenue of $1.02 billion during the quarter, compared to the consensus estimate of $1.02 billion. During the same quarter in the prior year, the firm posted $1.45 earnings per share. The firm’s revenue was up 6.0% compared to the same quarter last year. Plexus has set its Q4 2025 guidance at 1.820-1.970 EPS. Analysts expect that Plexus Corp. will post 5.9 EPS for the current year.

Plexus Company Profile

Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.